Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDB1- and CUL4-associated factor 17 (DCAF17) is a nuclear transmembrane protein that functions as a substrate receptor in Cullin-RING E3 ubiquitin ligase complexes, interacting primarily with DDB1 and CUL4 proteins[1][2][3][5]. Highly expressed in the testis, DCAF17 is crucial for gametogenesis and the development and maintenance of adult tissue homeostasis[1][2][5]. Loss-of-function mutations in DCAF17 cause Woodhouse-Sakati syndrome, a rare autosomal recessive multisystem disorder featuring hypogonadism, alopecia, diabetes mellitus, intellectual impairment, hearing loss, and extrapyramidal symptoms[1][2][3][4][5]. The protein is central to the protein ubiquitination pathway, particularly in the nucleolus, but its precise molecular substrates and mechanisms are not fully characterized. DCAF17 deficiency in animal models leads to impaired spermatogenesis and male infertility, underlining its essential role in reproductive and cellular processes[2][5]. No current evidence links DCAF17 to common therapeutic drug interactions or use as a clinical drug target[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 17 (DCAF17).